Multiplex analysis of the most common mutations related to hereditary haemochromatosis: two methods combining specific amplification with capillary electrophoresis Hereditary haemochromatosis (HH) is an ironloading disorder with an autosomal recessive mode of inheritance. This disease has been regarded as one of the most common genetic disorders of northern Europeans (1) with a prevalence of 1 in 300-400 in caucasian populations (2) . The phenotype of the disease is characterised by biochemical changes reflecting abnormal iron homeostasis, such as alterations in transferrin saturation and serum ferritin concentrations. Symptoms of haemochromatosis are the result of iron accumulation in a variety of organs. Thus, the most common clinical features are arthritis, cardiac arrhythmias, heart failure, diabetes mellitus, hepatic cirrhosis, hyperpigmentation, hypogonadism and, less commonly, hepatocellular carcinoma.
The HFE gene was cloned in 1996 (3) . Three point mutations in the HFE gene are considered responsible for the development of HH. The first and most clinically significant mutation is a G-to-A transition at nucleotide position 845 of the open reading frame. The resulting protein exhibits a change from cysteine to tyrosine at amino acid position 282. Homozygosity for the 845G fi A (C282Y) mutation has been found in more than 80% of patients diagnosed with iron overload Go´mez-Llorente C, Antu´nez A, Blanco S, Suarez A, Go´mez-Capilla JA, Farez-Vidal ME. Multiplex analysis of the most common mutations related to hereditary haemochromatosis: two methods combining specific amplification with capillary electrophoresis. Abstract: We present the first application of a multiplex multicolour assay for the simultaneous detection of three of the most frequent mutations related to hereditary haemochromatosis (C282Y, H63D and S65C), using fluorescent detection and capillary electrophoresis. We describe two methods: the first is based on a single base extension assay, resulting in a single base difference of the extended products; and the second is a competitive allele-specific polymerase chain reaction (PCR), based on competition between allele-specific primers. Specificity of the latter primers is enhanced with a mismatch at the antepenultimate nucleotide. Primers are designed to amplify products of different sizes and with different fluorescent dyes in order to accurately distinguish all possible combinations of genotypes (homozygous and heterozygous for each mutation) in a multiplex PCR analysis. An advantage of the present approach is that capillary electrophoresis analysis of the amplified products enables easy, rapid, unambiguous and high resolution discrimination between wild-type and mutant alleles, although different mutations may be present in the multiplex analysis. This will facilitate automated genotyping for routine molecular diagnostics and large-scale genetic studies. (3, 4) . The exchange of Y for C at position 282 of the a-3 domain of the HFE heavy chain disrupts the association with b-2 microglobulin, causing misfolding of the protein (5). The second and less clinically significant mutation is a C-to-G transversion at nucleotide position 187 of the open reading frame. The resulting protein exhibits a change from histidine to aspartic acid at amino acid position 63 (H63D). Compound heterozygotes for the C282Y and H63D mutations are also over-represented in the haemochromatosis population (6, 7) . The H63D mutation does not affect assembly or expression of HFE (8, 9) , and the biochemical effect of this mutation is unknown. Another point mutation (missense) associated with mild forms of haemochromatosis (10) is a third base alteration that replaces serine with cysteine at the polypeptide chain (S65C). This mutation is present in 1.5% of the European population (11, 12) .
Haemochromatosis is an inherited disease with a high prevalence in certain populations and is characterised by a long latent period before complications occur. It can be effectively treated if detected early, preventing hepatic, cardiac or endocrine dysfunctions and, therefore, reducing the morbidity and mortality among affected individuals (13) .
The revolution in molecular biology has enabled the ready determination of an individual's genotype at any given locus. This offers the possibility of carrying out genetic diagnosis and population screening to determine mutations associated with certain easily-treatable or -preventable illnesses. Requirements for genotyping methods include high specificity and reproducibility, low cost, avoidance of traditional electrophoresis systems (agarose, acrylamide) and toxic reagents, and amenability to automation. HH is considered by many experts to be an ideal candidate for population screening because it fulfils most of the aforementioned criteria, established by the World Health Organization in 1968 (14) . On the contrary, other experts have suggested that more data are required, especially on the penetration of the HH mutations.
Various molecular methods have been proposed for detecting HH mutations using polymerase chain reaction (PCR) coupled with different approaches, including restriction endonuclease analysis (15) (16) (17) , reverse dot-blot (18), allele-specific PCR (19) , allele-specific primer extension (20) (21) (22) , denaturing gradient gel electrophoresis (DGGE) (23) , oligonucleotide ligation assay (24) , single-strand conformational polymorphisms (SSCP) (25) and 5 ¢ nuclease assay (26, 27) .
The use of molecular technologies for the identification of single nucleotide polymorphisms (SNPs) has recently increased (28) because of the importance of SNPs as genetic markers for gene mapping, diagnosis of genetic and infectious diseases, and genotyping. Single base extension, a method to generate allele-specific products, has been applied in a growing number of studies because of its higher specificity in distinguishing between sequence variants and its simultaneous detection of all four possible bases at an SNP site in a one-tube reaction (ÔminisequencingÕ) (29) .
The present paper describes two methods for analysing mutations in haemochromatosis by using fluorescent detection and capillary electrophoresis. The first method employs a multiplex analysis that allows detection of the most common haemochromatosis mutations (C282Y, H63D and S65C) using a single base extension protocol. The second method is based on analysis by competitive allelespecific PCR for C282Y and H63D mutations. The advantage of the latter method is its lower cost. In both methods, the use of capillary electrophoresis and fluorescent detection bestows the additional benefits of accuracy, high resolution, semi-automation, rapid analysis, and low-sample consumption.
Materials and methods

DNA preparation
Study of mutations in the HFE gene was carried out in a series of 246 chromosomes from 123 patients suspected of having haemochromatosis. Whole blood samples were used for the preparation of human genomic DNA using a QIAampÒ Blood Mini Kit (Qiagen GmbH, Hilden, Germany). The concentration of samples was determined spectrophotometrically, using a UV-1603 Shimadzu (Kyoto, Japan) spectrophotometer.
Procedures were approved by the Ethical Committee of Human Experimentation, and are in accordance with the Helsinki Declaration of 1975.
Primers and reaction design for single nucleotide polymorphism determination
Oligonucleotide primers were designed to avoid the formation of primer-dimer, hairpin and self-complementarity in order to be compatible in the multiplex PCR. Primers were selected to amplify exon 2 of the HFE gene for H63D and S65C mutations, and exon 4 for C282Y mutation. Primers for SNP reactions differed in length by having poly dT tags of variable size at the 5 ¢ end. Annealing temperatures of primers were similar in order to allow performance of multiplex analysis. Primer sequences are shown in Table 1 . After the first PCR reaction primers and deoxynucleotide triphosphates (dNTPs), were removed by treatment of amplification products with 10 units of ExoI and 2 units of Shrimp alkaline phosphatase (SAP) at 37°C for 30 min followed by a step at 80°C for 15 min. Reactions were performed in a total volume of 25 lL containing 50 ng of DNA, 1 unit of AmpliTaq GoldÒ DNA polymerase and 1X PCR Buffer II (Applied Biosystems, Hispania SA), 1.5 mmol/L of MgCl 2 , 0.2 mmol/L of dNTPs, and primers at 0.2 lmol/L. Cycling parameters were 95°C for 10 min and 30 cycles of 94°C for 1 min, 52°C for 30 s and 72°C for 40 s, followed by a step at 72°C for 7 min. A second PCR reaction was performed using the ABI Prism Ò SNaPshot TM Kit (Applied Biosystems, Hispania, Spain) for polymorphism detection as recommended by the manufacturer. After this second amplification, products were treated with 1 unit of SAP at 37°C for 60 min followed by a step of 72°C for 15 min. Enzymes were provided by Amersham Biosciences Europe GmbH, Freiburg, Germany.
Primers and reaction design for competitive allele-specific PCR assay
Oligonucleotide primers were designed to avoid the formation of primer-dimer, hairpin and self-complementarity, in order to be compatible in the multiplex PCR. Primers were chosen to synthesise PCR products with a length of 139 and 149 bp and to have similar melting temperatures (Tm) to be compatible with the multiplex analysis. A common forward primer and two reverse allele-specific primers were designed according to the published sequence of the HFE gene. Reverse primers had a mismatch in the third nucleotide from the 3 ¢ end to enhance the specificity of the primers (as described in Results). The second nucleotide from the 3 ¢ end discriminates between the wild type and mutant form of each mutation (G or C for H63D mutation and C or T for C282Y mutation). Reverse primers that recognise wild-type were fluorescently labelled with 6-carboxifluorescein (6-FAM), and those recognizing mutant forms were labelled with 5-carboxitetrachlorofluoresceine (TET) at the 5 ¢ end. Table 2 shows primer sequences used in this study. One unit of AmpliTaq GoldÒ DNA polymerase and 1X PCR Buffer II (Applied Biosystems) was used for each PCR amplification. Best results were obtained under the following conditions: Taq polymerase, 1 U; dNTPs, 7 lmol/L; MgCl 2 , 1.5 mmol/L; DNA, 30 ng; oligonucleotides, 0.2 lmol/L. The optimal number of cycles was 28 cycles. Cycling parameters were 93°C for 5 min, followed by 28 three-step cycles of denaturation at 94°C for 48 s, annealing (optimal) at 54°C for 43 s and elongation at 62°C for 2 min, with a final step at 65°C for 7 min.
Capillary electrophoresis conditions
Fluorescently labelled products obtained from the SNPs and competitive studies were analysed on an ABI Prism 310 Genetic Analyzer (Applied Biosystems) using POP-4 polymer and silica capillaries of 47 cm length and 50 lm diameter.
For SNP products, electrophoresis was conducted with a GS STR POP-4 (1 mL) E module 5 and GS-Matrix-E five colour as matrix file. Before the analysis, 0.5 lL of SNP product was added to 9 lL deionized formamide and 0.5 lL Genescan TM -120 LIZ TM (Applied Biosystems, Hispania, Spain) (15, 20, 25, 35 , 50, 62, 80, 110 and 120 bp) as internal size standard. After a denaturation step at 95°C for 3 min, sample injections were conducted under 15 kV for 5 s. Separation was performed at 15 kV for 24 min at 60°C using filter set E.
For the competitive method, electrophoresis was conducted with a GS STR POP4 (1 mL) C module and GS-Matrix-C as matrix file. Before the analysis, 1 lL of amplified product was added to 18.5 lL of deionized formamide and 0. Primer designed in the complementary strand. Multiplex analysis for hereditary haemochromatosis as internal size standard. Samples were subjected to a denaturation step at 95°C for 3 min before loading them onto the autosampler. Samples were injected for 8 s at 15 kV. Separation was performed at 15 kV for 24 min at 60°C using filter set C. After the electrophoresis, data were analysed using GeneScan Analysis software version 3.7 (Applied Biosystems) with a GeneScan E matrix for SNP analysis (allowing the simultaneous analysis of five colours) and with a GeneScan C matrix for competitive products analysis. A calibration curve was constructed for each sample using the internal size standard.
DNA sequencing
The DNA sequencing was performed using the ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit v3.0 (Applied Biosystems), following the manufacturer's protocol, and was analysed on an ABI Prism 310. PCR products for sequencing were generated using forward and reverse primers for each mutation listed in Table 1 .
Results
For genotyping of codons 63, 65 and 282 of the HFE gene, fluorescently amplified PCR products were generated using two different methods: single base extension and competitive allele-specific amplification.
To validate these two methods, we sequenced all samples reported in this paper as well as random samples selected from the 123 individuals analysed. Results obtained with the methods reported here were fully consistent with those obtained by sequencing (data not shown).
Among the 123 individuals studied, nine were homozygous and 10 heterozygous for the C282Y mutation, and nine were homozygous and 42 heterozygous for the H63D mutation. We also found seven compound heterozygotes for C282Y/ H63D. We found one individual heterozygous for the S65C mutation and one compound heterozygous for C282Y and S65C mutations.
Single base extension assay
We carried out a multiplex assay in a single tube based on fluorescent detection and capillary electrophoresis analysis. The assay comprised two main steps: a PCR amplification and a primer extension reaction. The first PCR amplified DNA that contained the position of each mutation studied. Subsequently, an oligonucleotide primer annealed to the previously amplified template and extended a single dideoxynucleotide triphosphate (ddNTP) complementary to the nucleotide base of interest (30) . Incorporated ddNTP acted as terminator in the extension reaction, resulting in a single base difference of the extended products. This reaction showed a high specificity of single ddNTP incorporation catalysed by the DNA polymerase. Individual ddNTPs were fluorescently labelled [A was labelled with dR6G, colour analysed was green; C was labelled with dTAMRA TM , colour analysed was black; G was labelled with dR110, colour analysed was blue; and T (U) was labelled with dROX TM , colour analysed was red]. After each amplification reaction, the enzyme (Exonuclease I and SAP) treatment of amplified products avoided the misincorporation of nucleotides. This reaction showed a high specificity in distinguishing between sequence variants and allowed the simultaneous detection of all possible bases at an SNP site in a one-tube reaction (ÔminisequencingÕ). The polymerase incorporated guanine (blue), cytidine (black), or thymidine (red) for wild type C282Y, H63D or S65C, respectively, but adenine (green), guanine (blue) or adenine (green), for the mutant C282Y, H63D or S65C, respectively. Mobility of oligonucleotides subjected to capillary electrophoresis was determined by size, nucleotide composition and fluorophore. Because sizes of the oligonucleotide probes were different, products analysed by capillary electrophoresis resulted in reproducible and specific electrophoreses for each mutation. The electrophoregrams of heterozygous individuals comprised two peaks (different colour for each incorporated base), whereas those of homozygous individuals revealed a single peak, with the colour depending on the allele (wild type or mutant). A calibration curve was made for each sample using an internal size (LIZ-120) standard. This standard was fluorescently labelled and orange was the colour analysed. Software associated with capillary electrophoresis allowed the analysis of five colours for each sample. Figure 1 shows the multiplex analysis for each mutation described. The multiplex technique designed here allowed the accurate separation of the genotypes of patients in a single assay. The peak sizes exactly matched those expected for the fragments amplified (sizes were coincident for each analysis). Table 1 shows the SNPs and primer sequences analysed in this assay.
Competitive allele-specific polymerase chain reaction assay
We optimised detection conditions for the two most common point mutations related to haemochromatosis (C282Y and H63D). This method was also based on fluorescent detection and capillary electrophoresis analysis. A common forward primer and two reverse allele-specific primers were designed to hybridise with the published sequence of the HFE gene. This strategy resulted in the simultaneous amplification of both alleles (wildtype and mutant), thereby providing internal control of successful amplification (at least one of the allelic products should be visualised). The reverse primers had a mismatch in the third nucleotide from the 3 ¢ end. This mismatch is only expected to prevent amplification when the template sequence also contains an additional base change. Optimisation of the annealing temperature (45°-60°), buffer components (such as MgCl 2 between 0.5 and 3 mm), dNTP concentration (7-200 lm, DNA concentration (7-45 ng), primer concentration (0.1-0.4 lm) and amplification cycles (24-32) allowed amplification with the reverse primer-specific for the wild-type or mutant allele. Results from these experiments (data not shown) showed that best results were obtained under conditions described in the Material and Methods section. Primers were designed to amplify two products of different sizes for each mutation. Amplified fragments of 139 and 149 nucleotides were obtained for the C282Y and H63D mutations, respectively. Reverse primers were fluorescently labelled with two different fluorophores for wild-type (blue) and mutant (green) forms. Products analysed by capillary electrophoresis showed a single peak for homozygous individuals (blue for wild-type or green for mutant) or two equivalent peaks for heterozygous individuals (blue and green). Figures 2-4 show electrophoregrams with the multiplex analysis for each mutation described. It can be observed that there was no false annealing of primers. Peak sizes perfectly matched those expected for the amplicons studied. A calibration curve was constructed for each sample using an internal size (TAMRA-500) standard. Table 2 shows the primer sequences used in this assay. The individual genotypes obtained by the competitive PCR assay fully agreed with those obtained by the single base extension assay. Amplicons of 139 and 149 bp were visualised when the amplifications were performed with as little as 7 ng of chromosomal DNA, indicating the sensitivity of the technique.
Discussion
We report the first application of a multiplex multicolour assay for the simultaneous detection of three of the most common mutations related to HH (C282Y, H63D and S65C), using fluorescent detection and capillary electrophoresis. Data from sequences of DNA samples reported in this paper as well as others chosen at random (from the 123 analysed) confirmed the diagnosis obtained with both methods. SNPs, including neutral polymorphisms and disease-causing point mutations, occur on average every 1.3 kb in the human genome (31) . SNPs are typically bi-allelic, and are increasingly scrutinised in medical and population genetics studies to discriminate between alleles or haplotypes. The single base extension method reported here enables the specific and reproducible discrimination of mutations related to HH. It is a simple assay, and the allele analysis is carried out using a semiautomated laser-induced fluorescence capillary electrophoresis instrument. Our approach is based on (1) single base differences between alleles; (2) different capillary electrophoresis mobility of DNA fragments according to their size; (3) different capillary electrophoresis mobility of DNA fragments based on the presence of different fluorescently labelled ddNTPs; (4) peak size linearity; (5) analysis of five colours for each sample by the GeneScan version 3.5 software and (6) analysis reproducibility of the ABI Prism 310 capillary electrophoresis system. This study demonstrates the different capillary electrophoresis mobility of different fluorescently labelled products that differ only in their 3 ¢ base composition. Figure 1 shows that the analysis was highly accurate and specific and correct genotyped the codons under study. The mobility shifts of allele-specific SNPs products depend on the ddNTP terminator, primer sequences and specific fluorophore.
Furthermore, we have developed a competitive allele-specific PCR test that has several advantages over other traditionally used methods. It has a short response time and is simpler, safer (no acrylamide gels are required) and more economical (minimal volume of reagents and no need for restriction enzymes). The primers were designed so that the penultimate base of the respective primer recognised either G or A corresponding to Cys or Tyr at position 282 or recognised C or G corresponding to His or Asp at position 63. The antepenultimate nucleotide (third from the 3 ¢ end) was mismatched to enhance the specificity of the primers. A careful optimisation of reaction conditions, which minimised non-specific amplification and mismatch hybridisation, was critical to the development of this specific assay for HFE genotyping. Optimisation of annealing/hybridisation temperatures, primer and probe concentrations, buffer composition and, especially, dNTP concentration for each reaction separately and for the multiplex was essential to achieve the correct determination of genotypes. The use of a hot-start thermostable DNA polymerase was crucial to ensure both specific amplification and detection of the targeted HFE mutations. The coupling of capillary electrophoresis analysis with the assay added the advantages of accuracy, high resolution, semiautomation, rapid analysis and low-sample consumption. For this purpose, reverse primers were fluorescently labelled and sizes of amplicons were chosen to unambiguously identify HFE mutations. Peak sizes were precisely established by the linearity curve obtained for the internal size standard included for each sample.
For the development of the multiplex strategy in both methods, the PCR primers were designed to have close Tm values. In addition, the PCR primer sequences were designed so as not to generate any primer-primer or primer-probe interaction. Concentrations of the PCR primers were carefully adjusted so that both DNA sequences containing the targeted mutations were amplified to a similar extent. These assays may represent an alternative to previously published real-time PCR based assays (21, 22) .
The multiplex multicolour analysis offers numerous advantages over more traditional methods used for HFE mutation detection (3, 15, (32) (33) (34) , including greater speed and simplicity, reduced labour requirement, and lesser risk of cross-contamination. Furthermore, the competitive allele-specific PCR assay offers a welcome reduction in the costs of the analysis. The competitive method described here satisfies the requirements for a genotyping assay, i.e. high specificity and reproducibility, low cost, absence of traditional electrophoresis systems (agarose or acrylamide gels) and toxic reagents, and amenability to automation. Every health system in the Western world is under financial pressure as the demand for genetic diagnosis increases. At the same time, there is increasing controversy about the development of screening programmes for HH. Therefore, no screening programme proposal will gain credence or support unless it can be shown to be both effective and relatively inexpensive. On the contrary, if a diagnosis can be made early in the course of the disease, the delivery of appropriate treatment may not only improve the quality of life but also increase normal life expectancy. The present proposal of a compet- Fig. 3 . Electrophoregrams of the multiplex analysis of C282Y and H63D mutations using the competitive allele-specific polymerase chain reaction assay. (A) Heterozygous for H63D mutation and (B) mutant homozygous for H63D mutation.
itive method followed by capillary electrophoresis may represent an ideal design for the implementation of these assays.
